Mid-regional pro-adrenomedullin: An indicator of the failing Fontan circuit in patients with univentricular hearts?

European Journal of Heart Failure

Volumn 16, Issue 10, 2014, Pages 1082-1088

  Kaiser, Ralf ^a   Abdul Khaliq, Hashim ^a   Wilkens, Heinrike ^a   Herrmann, Eva ^b   Raedle Hurst, Tanja M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Failing Fontan circuit; Heart failure; Mid regional pro adrenomedullin; Univentricular heart

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GAMMA GLUTAMYLTRANSFERASE; PROADRENOMEDULLIN; ADRENOMEDULLIN; BIOLOGICAL MARKER; MID-REGIONAL PRO-ADRENOMEDULLIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; AORTA VALVE; AORTA VALVE REGURGITATION; AREA UNDER THE CURVE; ARTICLE; ASCITES; ATRIOPULMONARY CONNECTION; CAVOPULMONARY CONNECTION; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEVICE FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPH; FEMALE; FENESTRATION; FLOW RATE; FOLLOW UP; FONTAN PROCEDURE; HEART SINGLE VENTRICLE; HEART VOLUME; HUMAN; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; NEW YORK HEART ASSOCIATION CLASS; OXYGEN SATURATION; PERIPHERAL EDEMA; PREDICTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN LOSING GASTROENTEROPATHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VEIN DIAMETER; VENOUS CONGESTION; WEIGHT GAIN; ADVERSE EFFECTS; BLOOD; CONGENITAL MALFORMATION; HEART FAILURE; HEART VENTRICLE; HEART VENTRICLE FUNCTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SURGERY;

ADOLESCENT; ADRENOMEDULLIN; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHILD; FEMALE; FONTAN PROCEDURE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RISK ASSESSMENT; VENTRICULAR FUNCTION;

EID: 84907999499     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.158     Document Type: Article

References (27)

1. Gewillig M, Brown SC, Eyskens B, Heying R, Ganame J, Budts W, Gerche AL, Gorenflo M,. The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 2010; 10: 428-433.
2. Man BL, Cheung YF,. Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure. Heart Vessels 2007; 22: 398-403.
3. Ohuchi H, Takasugi H, Ohashi H, Yamada O, Watanabe K, Yagihara T, Echigo S,. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients. Circulation 2004; 110: 2601-2608.
4. Larsson DA, Meurling CJ, Holmqvist F, Waktare JE, Thilen UJ,. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007; 114: 345-351.
5. Raedle-Hurst TM, Koenigstein K, Gruenhage F, Raedle J, Herrmann E, Abdul-Khaliq H,. Growth differentiation factor 15-an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts. Am Heart J 2010; 160: 1105-1112.
6. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H,. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-1166.
7. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K,. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 1997; 95: 1214-1221.
8. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K,. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000; 101: 498-503.
9. Struck J, Tao C, Morgenthaler NG, Bergmann A,. Identification of an adreno-medullin precursor fragment in plasma of sepsis patients. Peptides 2004; 25: 1369-1372.
10. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H,. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995; 26: 1424-1431.
11. Jougasaki M, Wei CM, McKinley LJ, Burnett JC Jr,. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-289.
12. von Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W, Ponikowski P, Kremastinos D, Bergmann A, Morgenthaler NG, Anker SD,. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010; 12: 484-491.
13. Pousset F, Masson F, Chavirovskaia O, Isnard R, Carayon A, Golmard JL, Lechat P, Thomas D, Komajda M,. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 2000; 21: 1009-1014.
14. Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C,. Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care 2009; 13: R122.
15. Klip IT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, van Veldhuisen DJ, Dickstein K,. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 2011; 97: 892-898.
16. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD,. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010; 55: 2062-2076.
17. Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, Matsuoka H, Eto T, Matsuo H,. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20-years of age. Am J Cardiol 1997; 79: 1556-1558.
18. Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, Fukushima K, Nakanishi N, Takishita S, Miyata A, Kangawa K, Matsuo H, Kunieda T,. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci (Lond) 1999; 96: 33-39.
19. Hiramatsu T, Imai Y, Takanashi Y, Seo K, Terada M, Aoki M, Nakazawa M,. Time course of endothelin-1 and adrenomedullin after the Fontan procedure. Ann Thorac Surg 1999; 68: 169-172.
20. Watanabe K, Nishikimi T, Takamuro M, Yasuda K, Ishikawa Y, Tanabe S, Yamada O, Yagihara T, Suga S, Kangawa K, Matsuoka H, Echigo S,. Possible role of adrenomedullin in the regulation of Fontan circulation: mature form of plasma adrenomedullin is extracted in the lung in patients with Fontan procedure. Regul Pept 2007; 141: 129-134.
21. Wyatt HL, Heng MK, Meerbaum S, Gueret P, Hestenes J, Dula E, Corday E,. Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle. Circulation 1980; 61: 1119-1125.
22. Morgenthaler NG, Struck J, Alonso C, Bergmann A,. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005; 51: 1823-1829.
23. Ishida H, Kogaki S, Ichimori H, Narita J, Nawa N, Ueno T, Takahashi K, Kayatani F, Kishimoto H, Nakayama M, Sawa Y, Beghetti M, Ozono K,. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol 2012; 159: 34-39.
24. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Kangawa K, Eto T,. Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells. Life Sci 2001; 69: 239-245.
25. Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H,. Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 2003; 26 (Suppl): S121-S127.
26. Heaton J, Lin B, Chang JK, Steinberg S, Hyman A, Lippton H,. Pulmonary vasodila-tion to adrenomedullin: a novel peptide in humans. Am J Physiol 1995; 268: H2211-H2215.
27. Cheng DY, DeWitt BJ, Wegmann MJ, Coy DH, Bitar K, Murphy WA, Kadowitz PJ,. Synthetic human adrenomedullin and ADM15-52 have potent short-lasting vasodilator activity in the pulmonary vascular bed of the cat. Life Sci 1994; 55: PL251-PL256.